Mr. Zhang, General Manager of Biopharmaceutical Division at DP Technology, focuses on the industrialization of AI for Science in the fields of life sciences and drug research and development. He concentrates on the cutting-edge implementation of AI scientists, AI drug discovery, and the wet-dry closed-loop research and development paradigm, assisting pharmaceutical companies and research institutions in completing their intelligent transformation in research and development. Zhang Peng has held core positions at leading AI companies such as Fourth Paradigm and Baidu, where he was deeply involved in business analysis and expansion for machine learning, large language models (LLM), and biocomputing technologies, driving the implementation of multiple cutting-edge technological achievements.